Opsin Biotherapeutics, a pioneering biomedical technology company, announced a two-year, $2.35 million Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute …
Verily Health Inc., a precision health AI company, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department …
- NEWS
UTSW receives ARPA-H award to create functioning artificial liver: Newsroom – UT Southwestern, Dallas, Texas
UT Southwestern Medical Center has received an award from the Advanced Research Projects Agency for Health (ARPA-H) to develop livers using patients’ own cells and an innovative three-dimensional (3D) …
Dallas-based biotech startup MusiQ Bio, a UT Southwestern Medical Center spinoff, received a $2.59 million state grant to advance new cancer treatments. Date: 2026-09-29 dallasinnovates.com/dallas-biotech-startup-lands-2-6m-grant-to-fight-cancer/ …
MassChallenge, ranked the No. 2 accelerator in the U.S. by TIME and Statista, is deepening its commitment to Dallas, establishing the city as its second U.S. headquarters and expanding …
Irving-based Celanese Corp., a specialty materials and chemical company, has teamed up with Hong Kong-based VIGOR Precision Ltd., a manufacturer of plastic gears, to develop lightweight plastic joints for …
CG Oncology, a late-stage clinical biopharmaceutical firm, relocated its headquarters to Dallas from its location in Irvine, a city in Orange County. www.dallasnews.com/business/local-companies/article/7-billion-california-company-moved-headquarters-22400882.php
Astromech, the evolutionary biology AI company that spun out of Colossal Biosciences, has closed an additional $20 million in funding. To date, the company has raised $60 million and reports …
“DFW” fares best in workforce size and VC funding, scoring third with 26,000+ jobs and $218 million. The region also finishes sixth among emerging regions in NIH funding. www.genengnews.com/topics/drug-discovery/next-10-u-s-biopharma-clusters/
Dallas-Fort Worth only has 3.3 million square feet of lab space, says Cushman & Wakefield, but that number is expected to multiply in coming years since no less than 61.2 …
Newer Posts
